Learn languages naturally with fresh, real content!

tap to translate recording

Explore By Region

flag Atavistik Bio and Pfizer collaborate to develop new precision cancer treatments.

flag Atavistik Bio, a biotech firm specializing in precision allosteric therapeutics, has teamed up with Pfizer to accelerate the discovery of new treatments for unmet medical needs. flag Using Atavistik Bio's AMPS™ platform, the companies will identify novel allosteric binders for two undisclosed targets, aiming to expand the potential of precision oncology therapies. flag Pfizer has the option to license the resulting programs post-research.

5 Articles

Further Reading